GOLIMUMAB

golimumab 100 mg/mL injection, 1 mL pen device

GOLIMUMAB (11502J)

golimumab 100 mg/mL injection, 1 mL pen device
11502J
Manner of administration:Injection
General Schedule
Authority Required

Restriction

Indication: Moderate to severe ulcerative colitis
Treatment phase: Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 1 # of repeats: 1 DPMQ: $1,014.73 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Simponi